APO Research
Talk to an analyst

APO RESEARCH · REPORT

Asthma Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Asthma Drugs Market Outlook and Growth Opportunities 2026

20 December 2025192 pages

Choose your research edition.

Industry ResearchAsthma Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Asthma Drugs Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Asthma Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Asthma Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Asthma Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Asthma Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Asthma Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Asthma Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Asthma Drugs market include Teva Pharmaceutical, Novartis, Merck, Roche, Pfizer, GlaxoSmithKline, AstraZeneca, Vectura Group and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Asthma Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Asthma Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Asthma Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Asthma Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Asthma Drugs Segment by Company

Teva Pharmaceutical

Novartis

Merck

Roche

Pfizer

GlaxoSmithKline

AstraZeneca

Vectura Group

Boehringer Ingelheim

Asthma Drugs Segment by Type

Quick-relief Medications (Rescue Medications)

Medications for Allergy-induced Asthma

Asthma Drugs Segment by Application

Allergic Asthma

Non-Allergic Asthma

Asthma Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Asthma Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Asthma Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Asthma Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Asthma Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Asthma Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Asthma Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Asthma Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Asthma Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Asthma Drugs industry.

Chapter 3: Detailed analysis of Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Asthma Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Asthma Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Asthma Drugs Industry Trends Table 2. Asthma Drugs Industry Drivers Table 3. Asthma Drugs Industry Opportunities and Challenges Table 4. Asthma Drugs Industry Restraints Table 5. Global Asthma Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Asthma Drugs Revenue Share by Company (2021-2026) Table 7. Global Asthma Drugs Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Asthma Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Asthma Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Asthma Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Asthma Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Asthma Drugs Company, Product Type & Application Table 13. Global Asthma Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Quick-relief Medications (Rescue Medications) Table 18. Significant Companies of Medications for Allergy-induced Asthma Table 19. Global Asthma Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Asthma Drugs Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Asthma Drugs Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Asthma Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Asthma Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Asthma Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Asthma Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Asthma Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Asthma Drugs Sales Value Share by Type (2021-2026) Table 28. Global Asthma Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Allergic Asthma Table 30. Significant Companies of Non-Allergic Asthma Table 31. Global Asthma Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Asthma Drugs Sales Volume by Application (2021-2026) & (K Units) Table 33. Global Asthma Drugs Sales Volume by Application (2027-2032) & (K Units) Table 34. Global Asthma Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Asthma Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Asthma Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Asthma Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Asthma Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Asthma Drugs Sales Value Share by Application (2021-2026) Table 40. Global Asthma Drugs Sales Value Share by Application (2027-2032) Table 41. Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Asthma Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Asthma Drugs Sales Market Share by Region (2021-2026) Table 44. Global Asthma Drugs Sales by Region (2027-2032) & (K Units) Table 45. Global Asthma Drugs Sales Market Share by Region (2027-2032) Table 46. Global Asthma Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Asthma Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Asthma Drugs Sales Value Share by Region (2021-2026) Table 49. Global Asthma Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Asthma Drugs Sales Value Share by Region (2027-2032) Table 51. Global Asthma Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Asthma Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Global Asthma Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Asthma Drugs Sales by Country (2021-2026) & (K Units) Table 56. Global Asthma Drugs Sales Market Share by Country (2021-2026) Table 57. Global Asthma Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Asthma Drugs Sales Market Share by Country (2027-2032) Table 59. Global Asthma Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Asthma Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Asthma Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Asthma Drugs Sales Value Market Share by Country (2027-2032) Table 63. Teva Pharmaceutical Company Information Table 64. Teva Pharmaceutical Business Overview Table 65. Teva Pharmaceutical Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceutical Asthma Drugs Product Portfolio Table 67. Teva Pharmaceutical Recent Development Table 68. Novartis Company Information Table 69. Novartis Business Overview Table 70. Novartis Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Novartis Asthma Drugs Product Portfolio Table 72. Novartis Recent Development Table 73. Merck Company Information Table 74. Merck Business Overview Table 75. Merck Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Merck Asthma Drugs Product Portfolio Table 77. Merck Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Roche Asthma Drugs Product Portfolio Table 82. Roche Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Asthma Drugs Product Portfolio Table 87. Pfizer Recent Development Table 88. GlaxoSmithKline Company Information Table 89. GlaxoSmithKline Business Overview Table 90. GlaxoSmithKline Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. GlaxoSmithKline Asthma Drugs Product Portfolio Table 92. GlaxoSmithKline Recent Development Table 93. AstraZeneca Company Information Table 94. AstraZeneca Business Overview Table 95. AstraZeneca Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. AstraZeneca Asthma Drugs Product Portfolio Table 97. AstraZeneca Recent Development Table 98. Vectura Group Company Information Table 99. Vectura Group Business Overview Table 100. Vectura Group Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Vectura Group Asthma Drugs Product Portfolio Table 102. Vectura Group Recent Development Table 103. Boehringer Ingelheim Company Information Table 104. Boehringer Ingelheim Business Overview Table 105. Boehringer Ingelheim Asthma Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Boehringer Ingelheim Asthma Drugs Product Portfolio Table 107. Boehringer Ingelheim Recent Development Table 108. Key Raw Materials Table 109. Raw Materials Key Suppliers Table 110. Asthma Drugs Distributors List Table 111. Asthma Drugs Customers List Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Asthma Drugs Product Image Figure 2. Global Asthma Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Asthma Drugs Sales (2021-2032) & (K Units) Figure 5. Global Asthma Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Asthma Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Quick-relief Medications (Rescue Medications) Image Figure 10. Medications for Allergy-induced Asthma Image Figure 11. Global Asthma Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Asthma Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Asthma Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Asthma Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Asthma Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Asthma Drugs Sales Value Share by Type (2021-2032) Figure 17. Allergic Asthma Image Figure 18. Non-Allergic Asthma Image Figure 19. Global Asthma Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Asthma Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Asthma Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Asthma Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Asthma Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Asthma Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 26. Global Asthma Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Asthma Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Asthma Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Asthma Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Asthma Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Asthma Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Asthma Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Asthma Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Asthma Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Asthma Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Asthma Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Asthma Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Asthma Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Asthma Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Quick-relief Medications (Rescue Medications)
  • Medications for Allergy-induced Asthma
Applications
  • Allergic Asthma
  • Non-Allergic Asthma
Companies covered
  • Teva Pharmaceutical
  • Novartis
  • Merck
  • Roche
  • Pfizer
  • GlaxoSmithKline
  • AstraZeneca
  • Vectura Group
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Asthma Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Asthma Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Asthma Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Asthma Drugs Market Dynamics
  1. 2.1 Asthma Drugs Industry Trends
  2. 2.2 Asthma Drugs Industry Drivers
  3. 2.3 Asthma Drugs Industry Opportunities and Challenges
  4. 2.4 Asthma Drugs Industry Restraints
3 Asthma Drugs Market by Company
  1. 3.1 Global Asthma Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Asthma Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Asthma Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Asthma Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Asthma Drugs Company Ranking (2024-2026)
  6. 3.6 Global Asthma Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Asthma Drugs Company Product Type and Application
  8. 3.8 Global Asthma Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Asthma Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Asthma Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Asthma Drugs Market by Type
  1. 4.1 Asthma Drugs Type Introduction
  2. 4.1.1 Quick-relief Medications (Rescue Medications)
  3. 4.1.2 Medications for Allergy-induced Asthma
  4. 4.2 Global Asthma Drugs Sales Volume by Type
  5. 4.2.1 Global Asthma Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Asthma Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Asthma Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Asthma Drugs Sales Value by Type
  9. 4.3.1 Global Asthma Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Asthma Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Asthma Drugs Sales Value Share by Type (2021-2032)
5 Asthma Drugs Market by Application
  1. 5.1 Asthma Drugs Application Introduction
  2. 5.1.1 Allergic Asthma
  3. 5.1.2 Non-Allergic Asthma
  4. 5.2 Global Asthma Drugs Sales Volume by Application
  5. 5.2.1 Global Asthma Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Asthma Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Asthma Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Asthma Drugs Sales Value by Application
  9. 5.3.1 Global Asthma Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Asthma Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Asthma Drugs Sales Value Share by Application (2021-2032)
6 Asthma Drugs Regional Sales and Value Analysis
  1. 6.1 Global Asthma Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Asthma Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Asthma Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Asthma Drugs Sales by Region (2027-2032)
  5. 6.3 Global Asthma Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Asthma Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Asthma Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Asthma Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Asthma Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Asthma Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Asthma Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Asthma Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Asthma Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Asthma Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Asthma Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Asthma Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Asthma Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Asthma Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Asthma Drugs Sales Value Share by Country, 2025 VS 2032
7 Asthma Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Asthma Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Asthma Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Asthma Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Asthma Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Asthma Drugs Sales by Country (2027-2032)
  6. 7.4 Global Asthma Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Asthma Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Asthma Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Asthma Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Asthma Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Asthma Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Asthma Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Asthma Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Asthma Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Asthma Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Asthma Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Asthma Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Asthma Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Asthma Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Asthma Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Asthma Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Asthma Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Asthma Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Asthma Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Asthma Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Asthma Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Asthma Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Asthma Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Asthma Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Asthma Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Asthma Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Asthma Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Asthma Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Asthma Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Asthma Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Asthma Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Asthma Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Asthma Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Asthma Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Asthma Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Asthma Drugs Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Asthma Drugs Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Roche Asthma Drugs Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Asthma Drugs Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Asthma Drugs Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Asthma Drugs Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Vectura Group
  44. 8.8.1 Vectura Group Company Information
  45. 8.8.2 Vectura Group Business Overview
  46. 8.8.3 Vectura Group Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vectura Group Asthma Drugs Product Portfolio
  48. 8.8.5 Vectura Group Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Asthma Drugs Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Asthma Drugs Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Asthma Drugs Value Chain Analysis
  2. 9.1.1 Asthma Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Asthma Drugs Sales Mode & Process
  6. 9.2 Asthma Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Asthma Drugs Distributors
  9. 9.2.3 Asthma Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst